SecSonar.com

NRx Pharmaceuticals, Inc. (NRXP)

NRx Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

NRx Pharmaceuticals, Inc. (NRXP) is a Biotechnology company based in US with a market capitalization of $78.1M. Free cash flow was negative at -$14.1M. This page tracks NRXP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2 employees · IPO Dec 4, 2017

Valuation

Valuation & price

$3.28 · as of May 17, 2026 · -29.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.62$3.16$1.70Jul 25Dec 25Jul 26Jul 7, 25$3.37Jul 9, 25$3.36Jul 11, 25$3.21Jul 15, 25$3.11Jul 17, 25$3.03Jul 21, 25$2.98Jul 23, 25$3.03Jul 25, 25$3.00Jul 29, 25$2.88Jul 31, 25$2.69Aug 4, 25$2.72Aug 6, 25$2.46Aug 11, 25$2.32Aug 13, 25$2.53Aug 15, 25$2.89Aug 19, 25$2.51Aug 21, 25$2.53Aug 25, 25$2.69Aug 27, 25$2.58Aug 29, 25$2.32Sep 3, 25$2.60Sep 5, 25$2.75Sep 9, 25$3.15Sep 11, 25$2.88Sep 16, 25$2.98Sep 18, 25$2.98Sep 22, 25$2.87Sep 24, 25$2.99Sep 26, 25$2.95Sep 30, 25$3.30Oct 2, 25$3.33Oct 6, 25$3.35Oct 8, 25$3.58Oct 10, 25$3.17Oct 14, 25$3.05Oct 16, 25$3.04Oct 21, 25$3.21Oct 23, 25$3.20Oct 27, 25$3.14Oct 29, 25$3.05Oct 31, 25$3.10Nov 4, 25$2.74Nov 6, 25$2.67Nov 10, 25$2.54Nov 12, 25$2.64Nov 14, 25$2.49Nov 18, 25$2.28Nov 20, 25$2.03Nov 25, 25$2.18Nov 28, 25$2.45Dec 2, 25$2.27Dec 4, 25$2.44Dec 8, 25$2.26Dec 10, 25$2.21Dec 12, 25$2.07Dec 16, 25$2.10Dec 18, 25$2.18Dec 22, 25$2.41Dec 24, 25$2.44Dec 29, 25$2.60Jan 2, 26$2.62Jan 6, 26$2.39Jan 8, 26$2.33Jan 12, 26$2.22Jan 14, 26$2.15Jan 16, 26$2.27Jan 21, 26$2.26Jan 23, 26$2.17Jan 27, 26$2.24Jan 29, 26$2.12Feb 2, 26$2.15Feb 4, 26$1.84Feb 9, 26$1.99Feb 11, 26$1.82Feb 13, 26$1.80Feb 18, 26$1.78Feb 20, 26$1.84Feb 24, 26$1.89Feb 26, 26$1.93Mar 2, 26$1.81Mar 4, 26$1.87Mar 6, 26$1.70Mar 10, 26$1.81Mar 12, 26$1.80Mar 17, 26$1.95Mar 19, 26$1.84Mar 23, 26$1.77Mar 25, 26$2.41Mar 27, 26$2.19Mar 31, 26$2.13Apr 2, 26$2.20Apr 7, 26$2.23Apr 9, 26$2.26Apr 13, 26$2.28Apr 15, 26$2.52Apr 17, 26$2.55Apr 22, 26$2.97Apr 24, 26$2.94Apr 28, 26$2.95Apr 30, 26$2.98May 4, 26$3.00May 6, 26$3.05May 8, 26$3.08May 12, 26$2.87May 14, 26$3.21May 18, 26$3.12May 20, 26$2.97May 22, 26$3.22May 28, 26$4.44Jun 1, 26$4.62Jun 3, 26$4.05Jun 5, 26$4.14Jun 9, 26$3.87Jun 11, 26$3.92Jun 15, 26$4.08Jun 17, 26$3.98Jun 22, 26$3.90Jun 24, 26$3.56Jun 26, 26$3.73Jul 2, 26$3.87
$1.6852-week range$4.62
Loading valuation history…

Fundamentals

Key fundamentals

$78.1M

Market cap

—

Revenue growth (YoY)

58.8%

Gross margin

-$14.1M

Free cash flow (USD)

-$7.2M

Net debt

Net cash position

103.5%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$1.2M
$0$1.2M

Free cash flow by year

2017 → 2025

FY 2017$-135.8KFY 2018$-473.2KFY 2019$-792.7KFY 2020$-2.3MFY 2021$-37.7MFY 2022$-39.8MFY 2023$-21.7MFY 2024$-10.6MFY 2025$-14.1M
-$135.8K-$14.1M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.04)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCommon Stock OfferingJun 4, 2026Filing
  • 8-K eventPublic Offering AnnouncedJun 2, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing

Questions

Frequently asked questions

What is NRx Pharmaceuticals, Inc.'s market cap?

NRx Pharmaceuticals, Inc. (NRXP) has a market capitalization of $78.1M.

What is NRXP's P/E ratio?

A meaningful P/E ratio is not available for NRXP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did NRx Pharmaceuticals, Inc. last report earnings?

NRXP last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying NRXP stock?

SEC Form 4 filings show no open-market insider buys at NRx Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

PLRX

Pliant Therapeutics, Inc.

$78M

KPTI

Karyopharm Therapeutics Inc.

$77.4M

RLYB

Rallybio Corporation

$76.3M

CSBR

Champions Oncology, Inc.

$81M

HYFT

MindWalk Holdings Corp.

$82M

GANX

Gain Therapeutics, Inc.

$82.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.